Biogen Inc. buy BMO Capital Markets
Start price
09.11.23
/
50%
€211.40
Target price
09.11.24
€276.44
Performance (%)
-23.23%
End price
10.11.24
€162.30
Summary
This prediction ended on 10.11.24 with a price of €162.30. The prediction for Biogen Inc. disappointed with a performance of -23.23%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -0.924% | -0.924% | 22.336% |
| iShares Core DAX® | -0,68 % | -4,85 % | 1,94 % |
| iShares Nasdaq 100 | -0,03 % | 2,86 % | 18,90 % |
| iShares Nikkei 225® | -0,54 % | -5,02 % | 28,15 % |
| iShares S&P 500 | -0,21 % | 0,92 % | 13,69 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $314.00 to $295.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten